Elocon and Humira drug interactions - a phase IV clinical study of FDA data

Summary:

Drug interactions are reported among people who take Elocon (mometasone furoate) and Humira (adalimumab). Common drug interactions include lacrimation increased among females and psoriasis among males.

The phase IV clinical study analyzes what interactions people have when they take Elocon and Humira. It is created by eHealthMe based on reports of 43 people who take the same drugs from the FDA, and is updated regularly.

What is Elocon?

Elocon has active ingredients of mometasone furoate. It is often used in eczema. eHealthMe is studying from 2,019 Elocon users. Check the latest studies of Elocon.

What is Humira?

Humira has active ingredients of adalimumab. It is often used in rheumatoid arthritis. eHealthMe is studying from 761,396 Humira users. Check the latest studies of Humira.

eHealthMe: drug outcomes in the real world

eHealthMe runs one of the largest post-marketing drug safety studies in the world. We study millions of patients and 5,000 more each day. Our data-driven phase IV clinical trials have been referenced on 800+ peer-reviewed medical publications including The Lancet, Mayo Clinic Proceedings, and Nature. Tools to study our phase IV findings are available to the public, anonymous and free >>>.

On Aug, 27, 2026

43 people who take Elocon and Humira together, and have interactions are studied.

What are the common drug interactions of Elocon and Humira, by gender? *:

female:

Lacrimation increased
Lower respiratory tract infection
Occipital neuralgia (a condition characterized by chronic pain in the upper neck)
Paraesthesia (sensation of tingling, tickling, prickling, pricking, or burning of a person's skin with no apparent long-term physical effect)
Pathological fracture (broken bone caused by disease)
Sputum culture positive
Streptococcal urinary tract infection (a bacterial infection of urinary tract)
Swelling face
Visual impairment
Abortion spontaneous (naturally occurring miscarriage)

male:

Psoriasis (immune-mediated disease that affects the skin)
Erythrodermic psoriasis (generalized redness of the skin)
Drug ineffective
Drug specific antibody present
Fibrosis (formation of excess fibrous connective tissue in an organ or tissue)
Frequent bowel movements
Gastrointestinal erosion (gradual destruction of gastrointestinal tract because of the inflamed mucous membrane lining the stomach)
Haemorrhoids (a swollen vein or group of veins in the region of the anus)
Hepatic steatosis (fatty liver disease)
Ileal stenosis (obstruction in the ileal)

What are the common drug interactions of Elocon and Humira, by age (0-1 to 60+)? *:

0-1:

n/a

2-9:

Alopecia areata (patchy baldness that typically begins with rapid hair loss)

10-19:

Injection site pain
Injection site swelling
Joint stiffness
Pancreatitis (inflammation of pancreas)
Scleroderma (hard skin)

20-29:

n/a

30-39:

Psoriasis (immune-mediated disease that affects the skin)
Swelling face
Abortion spontaneous (naturally occurring miscarriage)
Arthralgia (joint pain)
Drug ineffective
Fatigue (feeling of tiredness)
Mental impairment (a condition affecting the body, perhaps through sight or hearing loss, a mobility difficulty or a health condition)
Pain
Raynaud's phenomenon (discoloration of the fingers, toes, and occasionally other areas)
Uterine cervical erosion (ulceration of the lining of the uterine cervix)

40-49:

Psoriasis (immune-mediated disease that affects the skin)
Drug ineffective
Erythrodermic psoriasis (generalized redness of the skin)
Infection
Injection site pain
Nasopharyngitis (inflammation of the nasopharynx)
Diffuse large b-cell lymphoma (cancer of b cells, a type of white blood cell)
Pathological fracture (broken bone caused by disease)
Arrhythmia (irregular heartbeat)
Hypertension (high blood pressure)

50-59:

Costovertebral angle tenderness
Haematuria (presence of blood in urine)
Inflammatory marker increased
Injection site haemorrhage (bleeding from injection site)
Injection site pain
Kidney infection
Nephrolithiasis (calculi in the kidneys)
Protein urine
Psoriasis (immune-mediated disease that affects the skin)
Skin lesion

60+:

Abdominal discomfort
Psoriasis (immune-mediated disease that affects the skin)
Dental caries
Gingival injury (gum injury)
Mastication disorder (disease of chewing food)
Memory impairment
Oral mucosal blistering (mouth ulcer)
Procedural pain
Sinus headache (headache caused by sinus infections)
Stomatitis (inflammation of mucous membrane of mouth)

What are the existing conditions these people have? *

Psoriasis (immune-mediated disease that affects the skin): 31 people, 72.09%
Psoriatic Arthropathy (inflammation of the skin and joints with kin condition which typically causes patches (plaques) of red, scaly skin to develop): 6 people, 13.95%
Pain: 4 people, 9.30%
Thyroid Diseases: 3 people, 6.98%
Migraine (headache): 3 people, 6.98%
Gastroesophageal Reflux Disease (a condition in which stomach contents leak backward from the stomach into the oesophagus): 3 people, 6.98%
Crohn's Disease (a condition that causes inflammation of the gastrointestinal tract): 3 people, 6.98%

* Approximation only. Some reports may have incomplete information.

Do you take Elocon and Humira?

- Personalize this study to your gender, age, symptoms and drugs
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously